MYELOID NEOPLASM
Clinical trials for MYELOID NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MYELOID NEOPLASM trials appear
Sign up with your email to follow new studies for MYELOID NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for frail AML patients: stronger chemo regimens tested
Disease control CompletedThis study tests whether giving full-strength chemotherapy (either CPX-351 or a combination called CLAG-M) can help medically less-fit adults with acute myeloid leukemia live longer and achieve remission. About 60 participants will receive one of the two treatments. The goal is t…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New combo therapy aims to improve survival in aggressive leukemia
Disease control CompletedThis large phase III trial tested whether adding the drugs bortezomib and sorafenib to standard chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) live longer without the cancer returning. Over 1,600 participants took part. The study focused on patients w…
Matched conditions: MYELOID NEOPLASM
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC